A Long-Term Clinical Study of SFPP in Patients with Osteoarthritis
Phase 3
- Conditions
- Osteoarthritis
- Registration Number
- JPRN-jRCT2080221798
- Lead Sponsor
- Taisho Pharmaceutical Co., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Outpatient
- Patients who require long-term NSAIDs treatment.
etc.
Exclusion Criteria
- Patients who are scheduled for surgery during the study period.
- Having critical hepatic disease, renal disease, heart disease and hematologic disease and malignant tumor.
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety
- Secondary Outcome Measures
Name Time Method Efficacy